Cargando…

Poor methodological reporting in lupus clinical trials found in Cochrane reviews

Detalles Bibliográficos
Autor principal:	Goldsmith, CH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467531/ http://dx.doi.org/10.1186/ar3988

Ejemplares similares

2078- Immunotherapy – 2078. Allergen-specific oral immunotherapy for peanut allergy: a Cochrane systematic review
por: Nurmatov, Ulugbek, et al.
Publicado: (2013)

Cluster Randomised Trials in Cochrane Reviews: Evaluation of Methodological and Reporting Practice
por: Richardson, Marty, et al.
Publicado: (2016)

Methodological quality of studies of end-stage renal disease risks in lupus nephritis
por: Tektonidou, Maria, et al.
Publicado: (2014)

Which lupus trial endpoints best reflect clinical judgment or biomarker improvement?
por: Thanou, A, et al.
Publicado: (2012)

Reporting and methodologic quality of Cochrane Neonatal review group systematic reviews
por: Al Faleh, Khalid, et al.
Publicado: (2009)

The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration
por: Turner, Lucy, et al.
Publicado: (2013)

Professional clinical guidelines for rare diseases: methodology
por: Kremp, Odile, et al.
Publicado: (2012)

Citation of updated and co-published Cochrane Methodology Reviews
por: Zhu, Linlin, et al.
Publicado: (2023)

Outcome measures in systemic lupus erythematosus: constructing a meaningful response index from existing clinical trial data
por: Forbess, Lindsy, et al.
Publicado: (2014)

Poor Reliability between Cochrane Reviewers and Blinded External Reviewers When Applying the Cochrane Risk of Bias Tool in Physical Therapy Trials
por: Armijo-Olivo, Susan, et al.
Publicado: (2014)

Epigenetics and lupus
por: Richardson, B
Publicado: (2012)

Review of clinical trials
por: Hendrick, RE
Publicado: (2002)

Clinical and immunological response to pneumococcal vaccination in pediatric systemic lupus erythematosus
por: Rigdon, D, et al.
Publicado: (2012)

Meeting abstracts from the 4th International Clinical Trials Methodology Conference (ICTMC) and the 38th Annual Meeting of the Society for Clinical Trials: Liverpool, UK. 07–10 May 2017
Publicado: (2017)

Area-level socioeconomic status and variation in medication use among Medicaid enrollees with incident systemic lupus erythematosus, 2000 to 2004
por: Feldman, CH, et al.
Publicado: (2012)

Lupus skin disease
por: Werth, Victoria P
Publicado: (2014)

DNA repair in lupus
por: Xu, Jiadi, et al.
Publicado: (2014)

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003)

Meeting abstracts from the 5th International Clinical Trials Methodology Conference (ICTMC 2019): Brighton, UK. 06-09 October 2019
Publicado: (2019)

Lymphoma risk in systemic lupus: effects of treatment versus disease activity
por: Clarke, AE, et al.
Publicado: (2012)

Genetic-epigenetic interaction in lupus
por: Sawalha, AH
Publicado: (2012)

Methodological challenges and issues of recruiting for mental health and substance use disorders trials in primary care
por: Henihan, Anne Marie, et al.
Publicado: (2015)

Modeling the stochastic behavior of lupus
por: Roopenian, Derry C, et al.
Publicado: (2014)

Variation in renal biopsy and medication prescribing practices among pediatric Medicaid patients with lupus nephritis prior to end-stage renal disease in the US, 2000 to 2004
por: Hiraki, LT, et al.
Publicado: (2012)

Preliminary population-based incidence and prevalence estimates of systemic lupus erythematosus: the California Lupus Surveillance Project
por: Dall'Era, Maria C, et al.
Publicado: (2014)

Lung cancer in systemic lupus erythematosus
por: Kale, M, et al.
Publicado: (2012)

Microparticles as autoantigens in human and murine lupus
por: Ullal, A, et al.
Publicado: (2012)

Blimp-1 and systemic lupus erythematosus
por: Diamond, Betty, et al.
Publicado: (2014)

Protective natural autoantibodies and lupus pathogenesis
por: Silverman, Gregg J
Publicado: (2014)

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Vasculitis and Systemic Lupus Erythematous (SLE)
por: Cortis, Elisabetta, et al.
Publicado: (2015)

Biologic Aspects of Nurse-Like Cells Found in Bone Marrow and Synovial Tissue of Rheumatoid Arthritis Patients
por: Ochi, Takahiro
Publicado: (2000)

Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
por: Isenberg, David, et al.
Publicado: (2014)

A methodology for refining AR-DRG
por: Aisbett, CW
Publicado: (2011)

Cooling methodology: to influence or to control the temperature?
por: Pellis, Tommaso
Publicado: (2015)

Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006
por: Feldman, Candace H, et al.
Publicado: (2014)

Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews
por: Jørgensen, Lars, et al.
Publicado: (2016)

Innate sensors for nucleic acids and lupus pathogenesis
por: Theofilopoulos, AN, et al.
Publicado: (2012)

Cytokine profiles of lupus patients with or without nephritis
por: Rovin, BH, et al.
Publicado: (2012)

Hopkins Lupus Cohort: assessment of treatment effects
por: Petri, M
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8ll832jg4tvdjonm5036v46n28